Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Más filtros

Medicinas Complementárias
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Undersea Hyperb Med ; 50(4): 421-424, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-38055883

RESUMEN

Introduction: Cerebral radiation necrosis is rarely encountered in pediatric patients. This case report describes a child with cerebral radiation necrosis who was successfully treated using corticosteroids, bevacizumab, and hyperbaric oxygenation. Case report: A 3-year-old boy developed progressive extremity weakness six months after the completion of radiation therapy for the treatment of a neuroepithelial malignancy. Treatment with corticosteroids and bevacizumab was initiated, but his symptoms did not improve, and he was then referred for hyperbaric oxygen therapy. After completing 60 hyperbaric treatments, he experienced significant improvements in mobility, which remained stable over the next year. Discussion: Cerebral radiation necrosis typically presents in children with symptoms of ataxia or headache. Corticosteroids and bevacizumab are common treatments, but hyperbaric oxygen therapy has also been studied as a therapeutic modality for this condition. When considering the use of hyperbaric oxygenation in pediatric patients, careful attention to treatment planning and patient safety can reduce the risks of adverse events such as middle ear barotrauma and confinement anxiety. Conclusion: In addition to other available pharmacologic therapies, hyperbaric oxygenation should be considered for the treatment of pediatric patients with cerebral radiation necrosis.


Asunto(s)
Lesiones Encefálicas , Cerebro , Oxigenoterapia Hiperbárica , Traumatismos por Radiación , Preescolar , Humanos , Masculino , Barotrauma/etiología , Barotrauma/prevención & control , Bevacizumab/uso terapéutico , Oxigenoterapia Hiperbárica/efectos adversos , Oxigenoterapia Hiperbárica/métodos , Necrosis/etiología , Necrosis/terapia , Cerebro/patología , Cerebro/efectos de la radiación , Lesiones Encefálicas/etiología , Lesiones Encefálicas/patología , Lesiones Encefálicas/terapia , Traumatismos por Radiación/etiología , Traumatismos por Radiación/patología , Traumatismos por Radiación/terapia , Neoplasias Neuroepiteliales/radioterapia
2.
Neuroradiology ; 63(8): 1185-1213, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-33779771

RESUMEN

PURPOSE: In addition to histology, genetic alteration is now required to classify many central nervous system (CNS) tumors according to the most recent World Health Organization CNS tumor classification scheme. Although that is still not the case for classifying pediatric low-grade neuroepithelial tumors (PLGNTs), genetic and molecular features are increasingly being used for making treatment decisions. This approach has become a standard clinical practice in many specialized pediatric cancer centers and will likely be more widely practiced in the near future. This paradigm shift in the management of PLGNTs necessitates better understanding of how genetic alterations influence histology and imaging characteristics of individual PLGNT phenotypes. METHODS: The complex association of genetic alterations with histology, clinical, and imaging of each phenotype of the extremely heterogeneous PLGNT family has been addressed in a holistic approach in this up-to-date review article. A new imaging stratification scheme has been proposed based on tumor morphology, location, histology, and genetics. Imaging characteristics of each PLGNT entity are also depicted in light of histology and genetics. CONCLUSION: This article reviews the association of specific genetic alteration with location, histology, imaging, and prognosis of a specific tumor of the PLGNT family and how that information can be used for better imaging of these tumors.


Asunto(s)
Neoplasias Encefálicas , Neoplasias del Sistema Nervioso Central , Glioma , Neoplasias Neuroepiteliales , Neoplasias Encefálicas/diagnóstico por imagen , Neoplasias Encefálicas/genética , Niño , Humanos , Mutación , Neoplasias Neuroepiteliales/diagnóstico por imagen , Neoplasias Neuroepiteliales/genética , Pronóstico
3.
Am J Med Genet A ; 173(4): 1061-1065, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28328117

RESUMEN

Noonan syndrome (NS), an autosomal dominant disorder, is characterized by short stature, congenital heart defects, developmental delay, and facial dysmorphism. PTPN11 mutations are the most common cause of NS. PTPN11 encodes a non-receptor protein tyrosine phosphatase, SHP2. Hematopoietic malignancies and solid tumors are associated with NS. Among solid tumors, brain tumors have been described in children and young adults but remain rather rare. We report a 16-year-old boy with PTPN11-related NS who, at the age of 12, was incidentally found to have a left temporal lobe brain tumor and a cystic lesion in the right thalamus. He developed epilepsy 2 years later. The temporal tumor was surgically resected because of increasing crises and worsening radiological signs. Microscopy showed nodules with specific glioneuronal elements or glial nodules, leading to the diagnosis of dysembryoplastic neuroepithelial tumor (DNT). Immunohistochemistry revealed positive nuclear staining with Olig2 and pERK in small cells. SHP2 plays a key role in RAS/MAPK pathway signaling which controls several developmental cell processes and oncogenesis. An amino-acid substitution in the N-terminal SHP2 domain disrupts the self-locking conformation and leads to ERK activation. Glioneuronal tumors including DNTs and pilocytic astrocytomas have been described in NS. This report provides further support for the relation of DNTs with RASopathies and for the implication of RAS/MAPK pathways in sporadic low-grade glial tumors including DNTs. © 2017 Wiley Periodicals, Inc.


Asunto(s)
Neoplasias Encefálicas/genética , Epilepsia/genética , Mutación , Neoplasias Neuroepiteliales/genética , Síndrome de Noonan/genética , Proteína Tirosina Fosfatasa no Receptora Tipo 11/genética , Adolescente , Adulto , Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico/genética , Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico/metabolismo , Neoplasias Encefálicas/diagnóstico , Neoplasias Encefálicas/patología , Neoplasias Encefálicas/cirugía , Niño , Epilepsia/diagnóstico , Epilepsia/patología , Epilepsia/cirugía , Quinasas MAP Reguladas por Señal Extracelular/genética , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Expresión Génica , Genes Dominantes , Humanos , Masculino , Neoplasias Neuroepiteliales/diagnóstico , Neoplasias Neuroepiteliales/patología , Neoplasias Neuroepiteliales/cirugía , Proteínas del Tejido Nervioso/genética , Proteínas del Tejido Nervioso/metabolismo , Síndrome de Noonan/diagnóstico , Síndrome de Noonan/patología , Síndrome de Noonan/cirugía , Factor de Transcripción 2 de los Oligodendrocitos , Proteína Tirosina Fosfatasa no Receptora Tipo 11/metabolismo , Lóbulo Temporal/metabolismo , Lóbulo Temporal/patología , Lóbulo Temporal/cirugía , Tálamo/metabolismo , Tálamo/patología , Tálamo/cirugía
5.
Korean Journal of Pediatrics ; : S139-S144, 2016.
Artículo en Inglés | WPRIM | ID: wpr-118689

RESUMEN

Encephalocraniocutaneous lipomatosis (ECCL) is a rare neurocutaneous syndrome that affects ectomesodermal tissues (skin, eyes, adipose tissue, and brain). The neurologic manifestations associated with ECCL are various including seizures. However, ECCL patients very rarely develop brain tumors that originate from the neuroepithelium. This is the first described case of ECCL in combination with dysembryoplastic neuroepithelial tumor (DNET) that presented with intractable seizures. A 7-year-old girl was admitted to our center because of ECCL and associated uncontrolled seizures. She was born with right anophthalmia and lipomatosis in the right temporal area and endured right temporal lipoma excision at 3 years of age. Seizures began when she was 3 years old, but did not respond to multiple antiepileptic drugs. Brain magnetic resonance (MR) imaging performed at 8 and 10 years of age revealed an interval increase of multifocal hyperintense lesions in the basal ganglia, thalamus, cerebellum, periventricular white matter, and, especially, the right temporal area. A nodular mass near the right hippocampus demonstrated the absence of N-acetylaspartate decrease on brain MR spectroscopy and mildly increased methionine uptake on brain positron emission tomography, suggesting low-grade tumor. Twenty-four-hour video electroencephalographic monitoring also indicated seizures originating from the right temporal area. Right temporal lobectomy was performed without complications, and the nodular lesion was pathologically identified as DNET. The patient has been seizure-free for 14 months since surgery. Although ECCL-associated brain tumors are very rare, careful follow-up imaging and surgical resection is recommended for patients with intractable seizures.


Asunto(s)
Niño , Femenino , Humanos , Tejido Adiposo , Anoftalmos , Anticonvulsivantes , Ganglios Basales , Encéfalo , Neoplasias Encefálicas , Cerebelo , Epilepsia Refractaria , Estudios de Seguimiento , Hipocampo , Lipoma , Lipomatosis , Espectroscopía de Resonancia Magnética , Metionina , Neoplasias Neuroepiteliales , Síndromes Neurocutáneos , Manifestaciones Neurológicas , Tomografía de Emisión de Positrones , Convulsiones , Tálamo , Sustancia Blanca
6.
Recenti Prog Med ; 104(2): 73-5, 2013 Feb.
Artículo en Italiano | MEDLINE | ID: mdl-23535962
7.
Anticancer Drugs ; 22(1): 104-10, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20938339

RESUMEN

Genotyping of putative determinants of temozolomide (TMZ)-induced life-threatening bone marrow suppression was performed in two patients with glioma treated with adjuvant TMZ and radiation therapy. DNA was extracted from the patients' mononuclear cells and genotyping of O-methylguanine-DNA-methyltransferase (MGMT), multidrug resistance (MDR1; also known as ABCB1), NQO1, and GSTP1 genes and analysis for the epigenetic silencing of specific MGMT gene promoters were carried out to evaluate the possible genetic determinants of increased risk of severe TMZ-induced myelosuppression. Although both patients were heterozygous for all ABCB1 single nucleotide polymorphisms and for rs12917 and rs1803965 in the MGMT gene, patient 1 was heterozygous for rs1695 in GSTP1 and rs2308327 in the MGMT gene. This patient also exhibited GG genotype for the MGMT single nucleotide polymorphisms, rs2308321, which is noteworthy for its 0.7% frequency globally. Epigenetic silencing of MGMT gene was not detected in either patient. Two single nucleotide polymorphisms identified in patient 1 (missense I143V and K178R polymorphisms; rs2308321 and rs2308327, respectively) have recently been shown to correlate with an increased risk of severe TMZ-induced myelosuppression. The polymorphisms identified in patient 2 have not been associated with an increased risk of severe TMZ-induced myelosuppression. Genotyping analyses of larger patient populations administered TMZ are required to validate the genetic determinants of severe TMZ-induced myelosuppression.


Asunto(s)
Antineoplásicos Alquilantes/efectos adversos , Dacarbazina/análogos & derivados , Glioma/tratamiento farmacológico , Trastornos Mieloproliferativos/inducido químicamente , Trastornos Mieloproliferativos/genética , Subfamilia B de Transportador de Casetes de Unión a ATP , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/genética , Adulto , Antineoplásicos Alquilantes/farmacología , Dacarbazina/efectos adversos , Dacarbazina/uso terapéutico , Femenino , Glioma/enzimología , Glioma/genética , Gutatión-S-Transferasa pi/genética , Humanos , Masculino , Persona de Mediana Edad , NAD(P)H Deshidrogenasa (Quinona)/genética , Neoplasias Neuroepiteliales/complicaciones , Neoplasias Neuroepiteliales/terapia , O(6)-Metilguanina-ADN Metiltransferasa/genética , Pacientes , Polimorfismo de Nucleótido Simple , Regiones Promotoras Genéticas , Temozolomida
8.
Artículo en Inglés | WPRIM | ID: wpr-26616

RESUMEN

OBJECTIVE: It is usually difficult to perform the neuroendoscopic procedure in patients without hydrocephalus due to difficulties with ventricular cannulation. The purpose of this study was to find out the value of navigation guided neuroendoscopic biopsy in patients with peri- or intraventricular tumors without hydrocephalus. METHODS: Six patients with brain tumors without hydrocephalus underwent navigation-guided neuroendoscopic biopsy. The procedure was indicated for verification of the histological diagnosis of the neoplasm, which was planned to be treated by chemotherapy and/or radiotherapy as the first line treatment, or establishment of the pathological diagnosis for further choice of the most appropriate treatment strategy. RESULTS: Under the guidance of navigation, targeted lesion was successfully approached in all patients. Navigational tracking was especially helpful in entering small ventricles and in approaching the third ventricle through narrow foramen Monro. The histopathologic diagnosis was established in all of 6 patients : 2 germinomas, 2 astrocytomas, 1 dysembryoplastic neuroepithelial tumor and 1 pineocytoma. The tumor biopsy sites were pineal gland (n = 2), suprasellar area (n = 2), subcallosal area (n = 1) and thalamus (n = 1). There were no operative complications related to the endoscopic procedure. CONCLUSION: Endoscopic biopsy or resection of peri- or intraventricular tumors in patients without hydrocephalus is feasible. Image-guided neuroendoscopic procedure improved the accuracy of the endoscopic approach and minimized brain trauma. The absence of ventriculomegaly in patients with brain tumor may not be served as a contraindication to endoscopic tumor biopsy.


Asunto(s)
Humanos , Astrocitoma , Biopsia , Encéfalo , Lesiones Encefálicas , Neoplasias Encefálicas , Cateterismo , Germinoma , Hidrocefalia , Neoplasias Neuroepiteliales , Neuroendoscopía , Glándula Pineal , Pinealoma , Tálamo , Tercer Ventrículo , Atletismo
9.
Prog. obstet. ginecol. (Ed. impr.) ; 51(10): 622-627, oct. 2008. ilus, tab
Artículo en Es | IBECS | ID: ibc-68579

RESUMEN

La gliomatosis peritoneal es una forma de extensión muy poco frecuente de los teratomas ováricos. Se caracteriza por la implantación miliar de tejido glial dentro de la cavidad peritoneal en pacientes con teratomas ováricos, generalmente inmaduros. Puede semejar un cuadro de carcinomatosis peritoneal. A pesar de su extensión intraperitoneal, la gliomatosis peritoneal no afecta adversamente al pronóstico del teratoma ovárico primario si los implantes de tejido glial se componen de tejido maduro y, por tanto, justifica tratamientos conservadores. El grado histológico del teratoma es el factor pronóstico que debe indicar el tratamiento complementario necesario. Su pronóstico es bueno, aunque se han descrito casos de malignización


Peritoneal gliomatosis is a very rare metastatic form of ovarian teratoma, characterized by miliary dissemination of glial tissue inside the peritoneal cavity in patients with an ovarian ­ usually immature ­ teratoma. Peritoneal gliomatosis may resemble peritoneal carcinomatosis. Despite peritoneal dissemination, if the glial tissue implants are composed of mature tissue, peritoneal gliomatosis does not adversely affect the prognosis of the primary ovarian teratoma. Consequently, conservative treatment is warranted. The main prognostic factor is the histological grade of the teratoma, which indicates the required complementary treatment. The prognosis of peritoneal gliomatosis is favorable, although cases of malignant transformation have been reporte (AU)


Asunto(s)
Humanos , Femenino , Adulto , Teratoma/patología , Neoplasias Ováricas/patología , Neoplasias Neuroepiteliales/patología , Neuroglía/patología , Fondo de Saco Recto-Uterino/patología , Neoplasias Peritoneales/patología
10.
Neurología (Barc., Ed. impr.) ; 22(6): 395-398, jul.-ago. 2007. ilus
Artículo en Es | IBECS | ID: ibc-62652

RESUMEN

Introducción. La gliomatosis cerebri es un trastorno neoplásico caracterizado por una infiltración difusa de células gliales con relativa conservación de las estructuras subyacentes. Las crisis comiciales, la cefalea y los trastornos del comportamiento suelen ser las manifestaciones iniciales.Caso clínico. Hombre de 38 años que presenta crisis parciales complejas y trastorno del comportamiento de 3 meses de evolución. En la resonancia magnética cerebral presenta lesiones hiperintesas en T2 sugerentes de gliomatosis cerebri, confirmándose con la biopsia cerebral. Varios meses después sufre un empeoramiento clínico rápido, evidenciándose el desarrollo de un glioblastoma multiforme sobre la lesión.Conclusiones. La gliomatosis cerebri, pese a su rareza, debe tenerse en cuenta en el diagnóstico diferencial de las lesiones infiltrativas difusas de la sustancia blanca. El empeoramiento clínico de rápida evolución y la aparición de lesiones focales que captan contraste nos deben hacer sospechar una trasformación a lesiones de mayor malignidad


Introduction. Gliomatosis cerebri is a neoplastic disorder characterized by diffuse infiltration of glial cells with relative conservation of the underlying structures. Seizures, headache and behavior disorders are generally the initial manifestations.Clínical case. A 38 year-old male who had complex partial seizures and behavior disorder of three months' evolution. The brain magnetic resonance imaging showed hyperintense lesions in T2 suggestive of gliomatosis cerebri, this being confirmed with the brain biopsy. Several months later, he suffered rapid clinical deterioration, observing the development of a glioblastoma multiforme over the lesion.Conclusions. In spite of its rareness, gliomatosis cerebri should be taken into account in the differential diagnoses of diffuse infiltrative lesions of the white matter. Rapid evolution clinical deterioration and the appearance of focal lesions that capture contrast should make us suspect a transformation to lesions of greater malignancy


Asunto(s)
Humanos , Masculino , Adulto , Neoplasias Neuroepiteliales/complicaciones , Glioblastoma/etiología , Neoplasias Neuroepiteliales/diagnóstico , Neoplasias Neuroepiteliales/patología , Glioblastoma/patología , Evolución Clínica , Diagnóstico Diferencial
11.
Neurochirurgie ; 51(3-4 Pt 2): 400-9, 2005 Sep.
Artículo en Francés | MEDLINE | ID: mdl-16292182

RESUMEN

BACKGROUND AND PURPOSE: The goal of this study was to analyze the main aspects of oligodendrogliomas observed in children. METHOD: The records of 35 children aged 15 years or younger (23 from Marseilles and 12 from Lyons) were reviewed. Clinical signs and symptoms, imaging findings (CT scan and pre- and post-operative MRI), extent of surgical resection, histology according to the WHO and Ste-Anne grading and survival were analysed. Considering all these factors, a statistical analyzis was undertaken in order to identify prognostic factors. DISCUSSION AND CONCLUSION: Oligodendrogliomas are rare tumors in children. The most important differential diagnosis to discuss is dysembryoplastic neuroepithelial tumor. Our study allowed us to distinguish several subgroups of patients with a different prognosis: thalamic tumors with a dismal prognosis versus hemispheric tumors. A group of cortical tumors we called "DNT-like" (hemispheric cortical tumor, isolated epilepsy, without neurological deficit and reased ICP, without edema and mass effect on MRI) with an excellent prognosis like the group with epilepsy. Histological grading (grade A/grade B and grade II/grade III) is also a prognostic factor.


Asunto(s)
Oligodendroglioma/cirugía , Neoplasias Supratentoriales/cirugía , Adolescente , Áreas de Influencia de Salud , Niño , Diagnóstico Diferencial , Femenino , Francia/epidemiología , Lateralidad Funcional , Humanos , Imagen por Resonancia Magnética , Masculino , Neoplasias Neuroepiteliales/patología , Oligodendroglioma/diagnóstico , Oligodendroglioma/mortalidad , Cuidados Posoperatorios , Neoplasias Supratentoriales/diagnóstico , Neoplasias Supratentoriales/mortalidad , Tasa de Supervivencia , Teratoma/patología , Tálamo/patología , Tálamo/cirugía
12.
J Pediatr Endocrinol Metab ; 17(5): 711-7, 2004 May.
Artículo en Inglés | MEDLINE | ID: mdl-15237704

RESUMEN

Pediatric patients with brain tumors can loose 1 SD of height prior to beginning growth hormone (GH) therapy. The objectives of this study were to characterize the early growth failure, identify contributing factors and propose interventions. Five children were followed quarterly for 2 years to monitor auxological parameters, nutritional indices, and endocrine measuremnts. GH stimulation tests were done every 6 months to determine the timing of the onset of GH deficiency. The nadir for height velocity (HV) occurred 6 months after diagnosis. Poor gains in height correlated with decreased calorie count (p <0.001), poor weight gain (p <0.001), decreased BMI (p <0.001) and lowered leptin levels (p <0.001). All patients were able to secrete GH normally during this nadir of growth. Children treated for brain tumors demonstrate an early triphasic pattern of growth. Growth failure due to cachexia occurs first, then a second transient phase of normal growth is observed followed by a third phase of growth failure due to GH deficiency. Phase 1 is characterized by decreased HV, BMI, leptin levels and calorie counts. With recognition of this profile, the early growth failure might be preventable with aggressive nutritional rehabilitation.


Asunto(s)
Estatura/efectos de la radiación , Neoplasias Encefálicas/radioterapia , Irradiación Craneana/efectos adversos , Trastornos del Crecimiento/etiología , Hormona de Crecimiento Humana/deficiencia , Hipotálamo/efectos de la radiación , Neoplasias Neuroepiteliales/radioterapia , Antineoplásicos/uso terapéutico , Estatura/efectos de los fármacos , Neoplasias Encefálicas/tratamiento farmacológico , Caquexia/fisiopatología , Niño , Preescolar , Terapia Combinada , Femenino , Estudios de Seguimiento , Trastornos del Crecimiento/sangre , Trastornos del Crecimiento/tratamiento farmacológico , Terapia de Reemplazo de Hormonas , Hormona de Crecimiento Humana/uso terapéutico , Humanos , Hipotálamo/fisiopatología , Leptina/sangre , Masculino , Neoplasias Neuroepiteliales/tratamiento farmacológico , Traumatismos por Radiación/complicaciones , Sobrevivientes
14.
J Clin Neurosci ; 8(4): 361-3, 2001 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-11437581

RESUMEN

We report two young patients with obscure presentations of gliomatosis cerebri. Initial CT scanning was inconclusive and in one case showed intraventricular haemorrhage, a feature not previously described. Magnetic resonance imaging was required to show the lesions with greater definition; however, in both cases, a biopsy was needed to confirm the diagnosis.


Asunto(s)
Neoplasias Encefálicas/patología , Hemorragias Intracraneales/patología , Neoplasias Neuroepiteliales/patología , Adulto , Neoplasias Encefálicas/diagnóstico por imagen , Diagnóstico Diferencial , Femenino , Humanos , Hidrocefalia/diagnóstico por imagen , Hidrocefalia/patología , Hemorragias Intracraneales/diagnóstico por imagen , Imagen por Resonancia Magnética , Neoplasias Neuroepiteliales/diagnóstico por imagen , Tálamo/patología , Tomografía Computarizada por Rayos X
15.
Klin Monbl Augenheilkd ; 218(5): 292-7, 2001 May.
Artículo en Francés | MEDLINE | ID: mdl-11417320

RESUMEN

PURPOSE: To remind of the absolute necessity for early diagnosis in the presence of ocular signs in children giving rise to possible intraocular tumours. METHOD: Based on our own experience of intraocular tumours in children, together with findings from the literature, diagnostic criteria and methods of treatment are presented. RESULTS: Retinoblastoma is the predominant cause of intraocular tumours in children, representing over 80% of cases under the age of 15 years. Other diseases may give rise to the same initial signs, usually leukocoria, sometimes strabismus, more rarely other atypical signs. Elements taken into account for diagnosis include age, sex, laterality, heredity, size of the globe, clinical aspect of the tumours, presence of calcifications and vitreous seeding. Full fundus examination under general anaesthetic is usually necessary. Biological examination, ultrasonography, computerized tomography and MRI enable an accurate diagnosis to be made in the majority of doubtful cases. The management of retinoblastoma is adapted for each individual case from the wide range of treatments available. Enucleation, radioactive applicators (...), brachytherapy (...), cryo- and photocoagulation represent classical measures. Primary chemotherapy, combined with other treatments such as thermotherapy, has become the treatment of choice in those cases where external beam radiotherapy has been used up to now, or in some instances before enucleation. Enucleation is usually carried out for medullo-epitheliomas, but brachytherapy may offer an alternative. CONCLUSION: Any unexplained ocular sign in children should be considered as a possible retinoblastoma, making an accurate and certain diagnosis imperative. Early treatment may save not only the life but also the vision of patients carrying this highly malignant lesion.


Asunto(s)
Neoplasias del Ojo/diagnóstico , Niño , Preescolar , Diagnóstico Diferencial , Neoplasias del Ojo/terapia , Humanos , Lactante , Neoplasias Neuroepiteliales/diagnóstico , Neoplasias Neuroepiteliales/terapia , Pronóstico , Neoplasias de la Retina/diagnóstico , Neoplasias de la Retina/terapia , Retinoblastoma/diagnóstico , Retinoblastoma/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA